NUVL
Nuvalent, Inc.
NASDAQ · Healthcare · Biotechnology · US
$123.96
+0.00%Latest reported
- Last report date
- May 7, 2026
- EPS actual
- -$1.39
- EPS estimate
- -$1.35
- Revenue actual
- —
- Revenue estimate
- $486.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -8.0%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| May 7, 2026 | -$1.35 | -$1.39 | Miss -2.96% | — |
| Oct 30, 2025 | -$1.39 | -$1.70 | Miss -22.30% | — |
| Aug 7, 2025 | -$1.27 | -$1.31 | Miss -3.15% | — |
| May 8, 2025 | -$1.14 | -$1.18 | Miss -3.51% | — |
| Feb 27, 2025 | -$1.04 | -$1.05 | Miss -0.96% | — |
| Aug 8, 2024 | -$0.76 | -$0.88 | Miss -15.79% | — |
| May 9, 2024 | -$0.67 | -$0.69 | Miss -2.99% | — |
| Feb 27, 2024 | -$0.59 | -$0.62 | Miss -5.08% | — |
| Nov 14, 2023 | -$0.59 | -$0.59 | In line | — |
| Aug 10, 2023 | -$0.53 | -$0.51 | Beat 3.77% | — |
| May 11, 2023 | -$0.51 | -$0.44 | Beat 13.73% | — |
| Mar 16, 2023 | -$0.43 | -$0.49 | Miss -13.95% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 6, 2026